CASI logo

CASI Pharmaceuticals (CASI) Total Assets

CASI Annual Total Assets

$75.27 M
-$20.97 M-21.79%

31 December 2023

CASI Total Assets Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

CASI Quarterly Total Assets

$63.62 M
+$12.35 M+24.08%

01 September 2024

CASI Quarterly Total Assets Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

CASI Total Assets Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-21.8%-15.5%
3 y3 years-41.1%-15.5%
5 y5 years-33.6%-15.5%

CASI Total Assets High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-45.6%at low-54.0%+24.1%
5 y5-year-45.6%at low-57.0%+24.1%
alltimeall time-45.6%+2226.1%-57.0%+2735.3%

CASI Pharmaceuticals Total Assets History

DateAnnualQuarterly
Sept 2024
-
$63.62 M(+24.1%)
June 2024
-
$51.27 M(-11.6%)
Mar 2024
-
$58.01 M(-22.9%)
Dec 2023
$75.27 M(-21.8%)
$75.27 M(+1.4%)
Sept 2023
-
$74.23 M(-4.7%)
June 2023
-
$77.87 M(-11.9%)
Mar 2023
-
$88.40 M(-8.1%)
Dec 2022
$96.23 M(-30.4%)
$96.23 M(-24.8%)
Sept 2022
-
$127.91 M(+7.6%)
June 2022
-
$118.86 M(-8.3%)
Mar 2022
-
$129.56 M(-6.3%)
Dec 2021
$138.30 M(+8.3%)
$138.30 M(+1.5%)
Sept 2021
-
$136.27 M(-5.7%)
June 2021
-
$144.53 M(-2.4%)
Mar 2021
-
$148.09 M(+15.9%)
Dec 2020
$127.73 M(+24.5%)
$127.73 M(-4.8%)
Sept 2020
-
$134.24 M(+46.6%)
June 2020
-
$91.57 M(-8.0%)
Mar 2020
-
$99.48 M(-3.1%)
Dec 2019
$102.63 M(-9.5%)
$102.63 M(-5.9%)
Sept 2019
-
$109.07 M(-6.8%)
June 2019
-
$117.09 M(-10.7%)
Mar 2019
-
$131.06 M(+15.6%)
Dec 2018
$113.41 M(+151.5%)
$113.41 M(-5.7%)
Sept 2018
-
$120.31 M(+37.2%)
June 2018
-
$87.71 M(+23.3%)
Mar 2018
-
$71.16 M(+57.8%)
Dec 2017
$45.10 M(+62.7%)
$45.10 M(+98.5%)
Sept 2017
-
$22.72 M(-5.9%)
June 2017
-
$24.13 M(-7.8%)
Mar 2017
-
$26.18 M(-5.5%)
Dec 2016
$27.71 M(+375.7%)
$27.71 M(+11.9%)
Sept 2016
-
$24.76 M(+30.5%)
June 2016
-
$18.97 M(+30.6%)
Mar 2016
-
$14.52 M(+149.3%)
Dec 2015
$5.83 M(-48.5%)
$5.83 M(-18.0%)
Sept 2015
-
$7.10 M(-17.2%)
June 2015
-
$8.58 M(-15.8%)
Mar 2015
-
$10.19 M(-9.9%)
Dec 2014
$11.31 M(-27.1%)
$11.31 M(-8.9%)
Sept 2014
-
$12.41 M(-8.0%)
June 2014
-
$13.48 M(-7.8%)
Mar 2014
-
$14.62 M(-5.7%)
Dec 2013
$15.51 M(+72.7%)
$15.51 M(-4.6%)
Sept 2013
-
$16.26 M(-7.3%)
June 2013
-
$17.54 M(-5.1%)
Mar 2013
-
$18.49 M(+105.9%)
Dec 2012
$8.98 M(+177.5%)
$8.98 M(-1.2%)
Sept 2012
-
$9.09 M(-11.2%)
June 2012
-
$10.23 M(-14.7%)
Mar 2012
-
$12.00 M(+270.9%)
Dec 2011
$3.24 M(-59.7%)
$3.24 M(+44.2%)
Sept 2011
-
$2.24 M(-44.8%)
June 2011
-
$4.07 M(-20.3%)
Mar 2011
-
$5.10 M(-36.5%)
Dec 2010
$8.04 M
$8.04 M(-9.4%)
Sept 2010
-
$8.87 M(+6.3%)
DateAnnualQuarterly
June 2010
-
$8.34 M(-16.7%)
Mar 2010
-
$10.02 M(-0.5%)
Dec 2009
$10.07 M(-65.2%)
$10.07 M(-27.3%)
Sept 2009
-
$13.85 M(-11.6%)
June 2009
-
$15.66 M(-26.8%)
Mar 2009
-
$21.39 M(-26.0%)
Dec 2008
$28.92 M(-45.4%)
$28.92 M(-10.8%)
Sept 2008
-
$32.42 M(-12.9%)
June 2008
-
$37.23 M(-16.8%)
Mar 2008
-
$44.74 M(-15.6%)
Dec 2007
$53.01 M(-4.9%)
$53.01 M(-4.6%)
Sept 2007
-
$55.58 M(+41.3%)
June 2007
-
$39.32 M(-17.0%)
Mar 2007
-
$47.35 M(-15.0%)
Dec 2006
$55.72 M(+52.9%)
$55.72 M(+27.2%)
Sept 2006
-
$43.81 M(-5.4%)
June 2006
-
$46.30 M(-10.3%)
Mar 2006
-
$51.65 M(+41.8%)
Dec 2005
$36.43 M(-7.5%)
$36.43 M(+0.4%)
Sept 2005
-
$36.27 M(-7.1%)
June 2005
-
$39.04 M(-13.9%)
Mar 2005
-
$45.33 M(+15.0%)
Dec 2004
$39.40 M(-1.9%)
$39.40 M(+56.1%)
Sept 2004
-
$25.24 M(-11.5%)
June 2004
-
$28.51 M(-13.9%)
Mar 2004
-
$33.10 M(-17.6%)
Dec 2003
$40.15 M(+44.4%)
$40.15 M(+73.9%)
Sept 2003
-
$23.09 M(-16.3%)
June 2003
-
$27.58 M(+47.9%)
Mar 2003
-
$18.65 M(-32.9%)
Dec 2002
$27.81 M(-39.8%)
$27.81 M(+209.2%)
Sept 2002
-
$8.99 M(-43.6%)
June 2002
-
$15.94 M(-48.3%)
Mar 2002
-
$30.86 M(-33.2%)
Dec 2001
$46.22 M(+47.1%)
$46.22 M(+0.0%)
Sept 2001
-
$46.21 M(+29.8%)
June 2001
-
$35.59 M(-26.8%)
Mar 2001
-
$48.62 M(+54.8%)
Dec 2000
$31.41 M(-1.4%)
$31.41 M(-29.7%)
Sept 2000
-
$44.65 M(-20.2%)
June 2000
-
$55.95 M(+59.3%)
Mar 2000
-
$35.13 M(+10.3%)
Dec 1999
$31.84 M(-19.6%)
$31.84 M(-30.2%)
Sept 1999
-
$45.60 M(+86.1%)
June 1999
-
$24.50 M(-24.8%)
Mar 1999
-
$32.60 M(-17.7%)
Dec 1998
$39.60 M(-17.2%)
$39.60 M(-3.4%)
Sept 1998
-
$41.00 M(-8.3%)
June 1998
-
$44.70 M(+1.6%)
Mar 1998
-
$44.00 M(-7.9%)
Dec 1997
$47.80 M(-11.6%)
$47.80 M(-1.0%)
Sept 1997
-
$48.30 M(-6.2%)
June 1997
-
$51.50 M(-0.6%)
Mar 1997
-
$51.80 M(-4.3%)
Dec 1996
$54.10 M
$54.10 M(-1.1%)
Sept 1996
-
$54.70 M(-3.5%)
June 1996
-
$56.70 M(+559.3%)
Mar 1996
-
$8.60 M

FAQ

  • What is CASI Pharmaceuticals annual total assets?
  • What is the all time high annual total assets for CASI Pharmaceuticals?
  • What is CASI Pharmaceuticals annual total assets year-on-year change?
  • What is CASI Pharmaceuticals quarterly total assets?
  • What is the all time high quarterly total assets for CASI Pharmaceuticals?
  • What is CASI Pharmaceuticals quarterly total assets year-on-year change?

What is CASI Pharmaceuticals annual total assets?

The current annual total assets of CASI is $75.27 M

What is the all time high annual total assets for CASI Pharmaceuticals?

CASI Pharmaceuticals all-time high annual total assets is $138.30 M

What is CASI Pharmaceuticals annual total assets year-on-year change?

Over the past year, CASI annual total assets has changed by -$20.97 M (-21.79%)

What is CASI Pharmaceuticals quarterly total assets?

The current quarterly total assets of CASI is $63.62 M

What is the all time high quarterly total assets for CASI Pharmaceuticals?

CASI Pharmaceuticals all-time high quarterly total assets is $148.09 M

What is CASI Pharmaceuticals quarterly total assets year-on-year change?

Over the past year, CASI quarterly total assets has changed by -$11.65 M (-15.48%)